Cannabis Drug Could Extend Lives of Brain Cancer Patients, Study Finds

UK drugmaker GW Pharmaceuticals announced Tuesday it has achieved positive results in the second phase of a clinical study on Glioma, a cannabinoid-based therapy aimed at treating an aggressive form of brain cancer. Read more »